By using control group with low Cbx4/VEGF expression as a reference, further, a joint statistical analysis between Cbx4 or VEGF expression and TAE/TACE treatment on HCC prognosis was performed. This evidence concerns the gene CBX4 and hepatocellular carcinoma.